Exogenous S1P Exposure Potentiates Ischemic Stroke Damage That Is Reduced Possibly by Inhibiting S1P Receptor Signaling
Initial and recurrent stroke produces central nervous system (CNS) damage, involving neuroinflammation. Receptor-mediated S1P signaling can influence neuroinflammation and has been implicated in cerebral ischemia through effects on the immune system. However, S1P-mediated events also occur within th...
Main Authors: | Eunjung Moon, Jeong Eun Han, Sejin Jeon, Jong Hoon Ryu, Ji Woong Choi, Jerold Chun |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2015/492659 |
Similar Items
-
Serum Sphingosine 1-Phosphate (S1P): A Novel Diagnostic Biomarker in Early Acute Ischemic Stroke
by: Jia Liu, et al.
Published: (2020-09-01) -
New possibilities of neuroprotection in ischemic stroke
by: D. V. Sergeyev, et al.
Published: (2011-12-01) -
Therapeutic efficacy of neuregulin 1-expressing human adipose-derived mesenchymal stem cells for ischemic stroke.
by: Sun Ryu, et al.
Published: (2019-01-01) -
Ischemic Stroke in Critically Ill Patients with Malignancy.
by: Jeong-Am Ryu, et al.
Published: (2016-01-01) -
MALAT1 Activates the P53 Signaling Pathway by Regulating MDM2 to Promote Ischemic Stroke
by: Ting Zhang, et al.
Published: (2018-11-01)